Content area
Full text
About the Authors:
Gen Suzuki
Affiliations Department of Medicine, Division of Cardiovascular Medicine, University at Buffalo, Buffalo, New York, United States of America, The Clinical and Translational Research Center, University at Buffalo, Buffalo, New York, United States of America
Brian R. Weil
Affiliations Department of Medicine, Division of Cardiovascular Medicine, University at Buffalo, Buffalo, New York, United States of America, The Clinical and Translational Research Center, University at Buffalo, Buffalo, New York, United States of America
Merced M. Leiker
Affiliations Department of Medicine, Division of Cardiovascular Medicine, University at Buffalo, Buffalo, New York, United States of America, The Clinical and Translational Research Center, University at Buffalo, Buffalo, New York, United States of America
Amanda E. Ribbeck
Affiliations Department of Medicine, Division of Cardiovascular Medicine, University at Buffalo, Buffalo, New York, United States of America, The Clinical and Translational Research Center, University at Buffalo, Buffalo, New York, United States of America
Rebeccah F. Young
Affiliations Department of Medicine, Division of Cardiovascular Medicine, University at Buffalo, Buffalo, New York, United States of America, The Clinical and Translational Research Center, University at Buffalo, Buffalo, New York, United States of America
Thomas R. Cimato
Affiliations Department of Medicine, Division of Cardiovascular Medicine, University at Buffalo, Buffalo, New York, United States of America, The Clinical and Translational Research Center, University at Buffalo, Buffalo, New York, United States of America
John M. Canty Jr
* E-mail: [email protected]
Affiliations Division of Cardiovascular Medicine, Veterans Affairs Western New York Health Care System, Buffalo, New York, United States of America, Department of Medicine, Division of Cardiovascular Medicine, University at Buffalo, Buffalo, New York, United States of America, Department of Physiology & Biophysics, University at Buffalo, Buffalo, New York, United States of America, Department of Biomedical Engineering, University at Buffalo, Buffalo, New York, United States of America, The Clinical and Translational Research Center, University at Buffalo, Buffalo, New York, United States of America
Introduction
A large number of preclinical studies have demonstrated the ability of diverse adult stem cell formulations to prevent post-infarction remodeling [1]. Stimulating resident progenitor cells or administering cell preparations that include exogenous cardiac stem cells may be particularly effective approaches to elicit cardiac repair. Although several stem and progenitor cell populations have been identified, there is compelling evidence that the reparative...